Scholarlink

Purpose <p>Fear of cancer recurrence (FCR) is one of the most prevalent and distressing psychological concerns among cancer survivors. This study examined the association between somatosensory amplification (SSA) and FCR and tested whether emotion regulation (ER) difficulties moderate this relationship.</p> Methods <p>A sample of 116 adult cancer survivors (<i>M</i>age = 47.24) completed validated self-report measures assessing SSA, ER difficulties, and FCR. Hierarchical regression analyses were conducted, controlling for anxiety symptom severity, age, gender, and time since treatment completion. Results: Neither SSA nor ER difficulties were associated with FCR. Yet, the interaction between SSA and ER difficulties was statistically significant. Specifically, the positive association between SSA and FCR was evident at low and mean levels of ER difficulties, but not at high levels. </p> Conclusions <p>Findings suggest that the relationship between heightened bodily sensitivity and FCR may differ according to levels of ER difficulties. Future research should explore longitudinal pathways and relevant intervention-based outcomes.</p> Implications for cancer survivors <p>Screening for SSA and ER difficulties in survivorship care may help identify individuals for whom heightened bodily sensitivity is associated with increased FCR.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Somatosensory amplification and fear of cancer recurrence: Moderating effects of emotion regulation difficulties

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月22日

查看全文
  • Shimrit Daches,
  • Ohad Zohar,
  • Shahaf Bitan,
  • Ilanit Hasson-Ohayon

摘要

Purpose

Fear of cancer recurrence (FCR) is one of the most prevalent and distressing psychological concerns among cancer survivors. This study examined the association between somatosensory amplification (SSA) and FCR and tested whether emotion regulation (ER) difficulties moderate this relationship.

Methods

A sample of 116 adult cancer survivors (Mage = 47.24) completed validated self-report measures assessing SSA, ER difficulties, and FCR. Hierarchical regression analyses were conducted, controlling for anxiety symptom severity, age, gender, and time since treatment completion. Results: Neither SSA nor ER difficulties were associated with FCR. Yet, the interaction between SSA and ER difficulties was statistically significant. Specifically, the positive association between SSA and FCR was evident at low and mean levels of ER difficulties, but not at high levels.

Conclusions

Findings suggest that the relationship between heightened bodily sensitivity and FCR may differ according to levels of ER difficulties. Future research should explore longitudinal pathways and relevant intervention-based outcomes.

Implications for cancer survivors

Screening for SSA and ER difficulties in survivorship care may help identify individuals for whom heightened bodily sensitivity is associated with increased FCR.